Transplantation. Jul 27;66(2) Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients. Minghelli G(1). This agent promotes uric acid excretion via effects on the organic anion transport The AIIA losartan also produces a uricosuric effect in healthy volunteers. Uricosuric medications (drugs) are substances that increase the excretion of uric acid in the urine, thus reducing the concentration of uric acid in blood plasma. In general, this effect is achieved by action on the proximal tubule of the the uricosurics benzbromarone and losartan had no effect, suggesting these drugs act.
|Published (Last):||3 April 2013|
|PDF File Size:||20.21 Mb|
|ePub File Size:||12.86 Mb|
|Price:||Free* [*Free Regsitration Required]|
A total of 57 patients were analyzed at 12 weeks. National Center for Biotechnology InformationU.
There were no statistical differences in the baseline values of Scr 0. Table 2 shows the effect of benzbromarone and losartan on the renal excretion of urate in four hypouricemic hypertensive patients harboring URAT1 mutations hypertensive case nos.
Thus, we postulate that losartan induces a particularly brisk response of BP regardless of Sur values. Effect of losartan and benzbromarone on renal excretion of urate in hypouricemic hypertensive patients carrying the mutant URAT1 gene. Serum levels of potassium and uric acid were elevated. Asymptomatic hyperuricemia can occur and, treatment with urate-lowering therapy most commonly occurs only in high risk patients such as those with a history of multiple gout attacks [ Khanna et al.
Individuals with a history of secondary hypertension, history of gout and renal lithiasis in the last 2 years, history of malignant hypertension, history of CVA within the last 2 years and history of cardiac arrhythmia were all excluded from this study.
In addition, it is estimated that employed individuals diagnosed with gout miss 5 days more per year than their counterparts without the disease. Table 1 summarizes the SLC22A12 genes and clinical characteristics of five hypertensive patients and four normotensive patients with idiopathic renal hypouricemia. Although beyond the scope of this review, other clinically meaningful results unrelated to gout manifestations have been reported. Candesartan and irbesartan were the other ARBs found in the literature that were compared to losartan for their potential uricosuric effects.
This review explored evidence for ARBs and the reduction of serum uric acid levels and increased fractional excretion of uric acid. Taken together, these findings show that the effects of these angiotensin receptor blockers on urate excretion are not influenced by renal adaptation.
In some persons with loss-of-function mutations of URAT1, the uricosurics benzbromarone and losartan had no effect, suggesting these drugs act on URAT1 in vivo.
The effect of angiotensin II receptor blockers on hyperuricemia
Patients and clearance study in hypertensive uricouric. These findings were compatible with the diagnosis of idiopathic renal hypouricemia. Potassium and serum creatinine levels were reviewed and both lab values remained within accepted normal ranges throughout the study uricosuricc Dang et al. ARB clinical trials around the turn of the millennium. This study did not complete a safety analysis [ Elisaf et al. This adverse effect was not expected, although this raises an important concern with chronically elevated serum uric acid levels precipitating gout attacks.
How to cite this article: The URAT1 inhibitor did not modify urate excretion in the URAT1-deficient patients with or without impaired renal function, indicating impaired renal function associated with idiopathic renal hypouricemia did not affect the results of the URAT1 inhibitor loading test.
Thirty-two patients with hypertension and nine patients with idiopathic renal hypouricemia five with and four without hypertension were enrolled for this study. Uromodulin in a pathway between decreased renal urate excretion and albuminuria.
Dang and colleagues conducted a multicenter study across 20 clinical institutions exploring the effects on serum uric acid levels after administration of losartan or irbesartan [ Dang et al. Overall, ARBs are well tolerated; posartan, the most common adverse effects include hypotension, hyperkalemia and increased serum creatinine levels [ Taylor et al. Four studies evaluated safety effects of these agents indicating abnormalities such as minor changes in lab values.
Uricosuric effect of losartan in patients with renal transplants.
In this regard, we had previously reported that losartan significantly increased urate excretion 2 h after its administration, 4 and that the increase was similar after 1 month of treatment. Contributor Information Marissa L. There were no significant changes in biochemical parameters such as liver enzymes, serum levels of creatinine, etfect and bicarbonate.
In hypertensive case no. Losartan induced a significant increase in Cur 4. The angiotensin receptor blocker losartan inhibited urate transporter 1 URAT1 according to in vitro experiments.
It is important to continue to monitor for the side effects that were found within the studies, as well as the common adverse effects associated with ARB use. A month after the benzbromarone test, the patients received 50 mg oral losartan and the same measurements were taken. It is important to note that their use would be limited by potential for hypotension [ Rayner et al.
Changes in lab values such as elevations in serum creatinine and potassium were noted; however, these results were deemed clinically insignificant as they remained within normal limits [ Dang et al. Upon review of the three studies which looked at the uricosuric effects of candesartan and irbesartan, there was no significant benefit with use of these agents [ Dang et al. The ACR Guidelines endorse the use of additional uricosuric agents such as fenofibrate and losartan in combination with xanthine oxidase inhibitors if target urate levels are not met with first-line agents alone [ Khanna et al.
However, only two of the studies evaluated the use of losartan in combination with hydrochlorothiazide in those with elevated blood pressure at baseline, and it was found to have a beneficial effect on blood pressure lowering in these patients [ Shahinfar et al.
The hypotensive and uricosuric effect of valsartan compared to losartan in gout patients. Interaction of nonpeptide angiotensin II receptor antagonists with the urate transport in rat renal brush-border membranes. However, it is still unknown whether the inhibitory effect of losartan on URAT1 contributes to its uricosuric action in humans. Am J Hypertens ; Therefore ARBs play a significant role in the treatment of hypertension and as renoprotective agents [ Michel et al.